AI-driven healthcare solutions provider Tempus AI (TEM) has disclosed acquisition of Deep 6 AI, a precision research platform ...

Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine and patient care ...

Tempus AI (TEM) announced it has acquired Deep 6 AI. Deep 6 AI enables healthcare organizations to de-risk clinical trials, accelerate ...

Tempus AI TEM, an innovator in artificial intelligence ... outperforming the 16.5% rise of the Medical Info Systems industry and the benchmark’s 6.8% increase. In the meantime, the Medical ...

Tempus AI's Q4 financials were slightly below expectations but aligned with preliminary results. See why I remain bullish on TEM stock.

CompanyOverview\|NASDAQ:TEM] Tempus AI (NASDAQ: TEM) is an emerging AI player in the healthcare field with a robust outlook ...

Tempus AI's slowing growth, cash flow issues, and net debt raise doubts about its sustainability. Explore key concerns and market outlook.

Genomics revenue grew 30.6% year-over-year to $120.4 million and unit growth came in at 22.5%. Tempus AI ended the quarter with $940 million in total remaining contract value and 140% net revenue ...

In the fourth quarter of 2024, Tempus AI posted 35.8% year-over-year revenue growth driven by strong 30.6% year-over-year sales growth in Genomics with unit growth of 22.5%. Data and services too ...

Tempus AI has raised an additional $300 million in incremental debt financing from alternative investment manager Ares Management that is intended to support the firm's recent acquisition of Ambry ...

Genomics grew 30.6% year-over-year to $120.4 million and unit growth came in at 22.5% year-over-year. Tempus AI said it ended the quarter with $940 million in total remaining contract value and ...